ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Labviva Announces Key Executive Appointments to Drive Global Expansion

BOSTON, June 17, 2025 (GLOBE NEWSWIRE) -- Labviva, the leading AI procurement platform for life sciences, today announced the expansion of its executive leadership team with the appointment of three key executives: Renika Sehgal as Chief Operating and Financial Officer, Jennifer Olszewski as Chief Marketing Officer, and Nick Premnath as Senior Vice President of Commercial Strategy. This announcement follows the company's recent $25 million Series B funding round, the hiring of European General Manager Dr. Carlo Iannicola, and the establishment of its international headquarters in London. These new appointments round out a global executive team that is uniquely capable of driving Labviva’s next phase of growth.

“Labviva provides significant cost savings and efficiencies for research organizations worldwide, which is enabling our growth despite federal research funding cuts, tariffs, and trade wars,” said Siamak Baharloo, co-founder and CEO of Labviva. “Today, I’m delighted to announce the carefully selected appointments of Renika, Jennifer, and Nick to our team. I look forward to their strategic contributions as we expand operations globally.”

New Appointments Deepen Labviva’s Executive Bench

Renika Sehgal, COO & CFO
Renika brings two decades of experience leading strategic financial and operational transformation, mainly in global healthcare and technology companies. At Labviva, she will oversee all financial and corporate operating activities, focused on supporting Labviva’s continued growth. Most recently, Renika served as the Chief Financial Officer at Biofourmis, a health technology & clinical service company, where she was a critical leader in enabling growth and executing a strategic merger. Earlier in her career, Renika was CFO at Cynosure and held segment CFO roles within GE Healthcare and American Tower, where she developed expertise in scaling both small and large-scale business across multiple markets. Renika holds a BS degree from Babson College.

Jennifer Olszewski, CMO
Jennifer is a seasoned marketing executive with three decades of experience building strong brands, increasing shareholder value, and facilitating profitable exits. As CMO, Jennifer oversees corporate, customer, and product marketing, as well as public relations and industry analyst relations. In 2003, Jennifer founded PenVine, a public relations firm that represents large multi-billion-dollar companies, unicorns, and startups across the global technology ecosystem. Prior to that, she served as Vice President of Marketing and Corporate Communications for Orcom, where she successfully rebranded the legacy software company by defining its Software as a Service (SaaS) go-to-market model. Her efforts generated significant marketing momentum, ultimately leading to Orcom's acquisition by Alliance Data Systems.

Nick Premnath, SVP of Commercial Strategy
Nick Premnath has joined Labviva as SVP of Commercial Strategy, where he’ll lead the commercial organization and overall go-to-market strategy. Nick brings over a decade of experience at the intersection of R&D and technology, with a track record of advising top life sciences companies on digital transformation and scaling high-performing commercial teams. Prior to Labviva, he held leadership roles in business development, consulting, and engineering across Science Exchange, Deloitte, Merck, Stryker, and Johnson & Johnson. He holds BS and MS degrees in Biomedical Engineering from Drexel University.

This has been a momentous year for Labviva, and we’ve reached a point where expanding our executive leadership team is essential for continuing our upward trajectory,” said Nick Rioux, co-founder and CTO of Labviva. “Since our founding, Siamak and I have taken on many roles to build Labviva from the ground up. We are excited to welcome these exceptional leaders who will help us expand customer support, forge relationships with new suppliers and manufacturers, and advance the digital transformation of the life sciences industry, beginning with procurement.”

To learn more about Labviva, visit www.labviva.com.

About Labviva
Labviva connects researchers with suppliers of reagents, chemicals, consumables, and instrumentation in an intuitive, user-friendly platform that supports the priorities of scientists while staying compliant with purchasing rules. Suppliers can easily manage the content of their products, and products are mapped into scientific applications, techniques and protocols. To learn more about how Labviva accelerates the science of life, visit us at www.labviva.com.

Media Contacts:

Gabby Lescarbeau
PenVine for Labviva
413-896-1991
gabby@penvine.com


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.